
Every serious investor has experienced this painful moment — you bought a quality stock, it ran up 80% or 100%, and you sold it to “lock in profits.” The stock then went on to deliver 500%, 1,000%, or even 5,000% returns over the next decade. You watch from the sidelines, kicking yourself for selling too early, but you refuse to buy it back because the price is now “too high.” This single psychological mistake has cost Indian investors more wealth than any market crash in history.
Warren Buffett, the greatest investor of all time, captured this perfectly when he said:
“The biggest mistakes are not the ones that show up on your scoreboard — they are the mistakes of omission rather than commission. It’s the things I knew enough to do and didn’t do.”
In Buffett’s own estimation, his mistakes of omission have cost Berkshire Hathaway shareholders over $10 billion in missed profits. These are not losses from bad investments — these are enormous gains that were left on the table because he hesitated, second-guessed himself, or failed to act when the evidence was clear.
For Indian investors, this lesson is even more critical. If you sold a quality compounder too early and the business fundamentals keep improving, buying it back at a higher price is not a mistake — it is the smartest move you can make.
Table of Contents
When you sell a stock at ₹200 and it rises to ₹400, your brain screams: “I sold at ₹200! I cannot buy at ₹400! That is double my selling price!” This is called anchoring bias — one of the most destructive cognitive errors in investing. Your old selling price has absolutely no relevance to whether the stock is a good investment today. The only things that matter are the current fundamentals, the future earnings trajectory, and the valuation relative to that trajectory.
Peter Lynch, the legendary Fidelity fund manager who delivered 29.2% annualised returns over 13 years, warned investors about this exact trap:
“Selling your winners and holding your losers is like cutting the flowers and watering the weeds.”
Lynch further observed that in his career, the biggest winners in his portfolio were stocks he bought, sold, and then bought again at higher prices when he realised the growth story was still intact. He repeatedly emphasised that the stock does not know you own it — and it certainly does not know at what price you previously sold it.
Let us look at three of India’s greatest wealth-creating stocks and what happened to investors who sold “too early” and never bought back:
An investor who bought HDFC Bank at ₹50 in 2001 and sold at ₹150 in 2004 — booking a handsome 200% gain — would have felt brilliant. But HDFC Bank went on to reach ₹1,700+ over the next two decades. The “smart” profit-booking of ₹100 per share cost the investor ₹1,550+ per share in missed gains. Even if that investor had bought back at ₹300 (double the selling price), they would still have made over 5x their reinvestment.
The lesson? A 200% gain feels wonderful — until you realise you left a 3,300%+ gain on the table. The fundamentals — loan book growth, asset quality, return on equity, management quality — kept improving at every stage. Buying back at any price during that journey would have been the right decision.
Countless Indian investors sold Infosys in the early 2000s after the dot-com crash, booking whatever profits they had. Those who refused to buy back — even when the company’s earnings consistently grew 20-30% annually for years afterward — missed one of the greatest wealth compounding stories in Indian corporate history. Infosys went from a post-crash low near ₹50 (adjusted) to over ₹1,900 today. Investors who recognised their mistake and bought back even at ₹200 or ₹500 still generated extraordinary returns.
An investor who bought Asian Paints at ₹20 (adjusted) in the early 2000s and sold at ₹60, booking a tidy 200% return, would have missed the stock’s subsequent journey to ₹3,000+. The ₹40 per share profit pales in comparison to the ₹2,940+ that was left on the table. Even re-entering at ₹200 — more than triple the selling price — would have delivered 15x returns.
The pattern is unmistakable: with quality businesses, the “high” price of today becomes the “low” price of tomorrow.
This is not just Buffett’s view. Virtually every great investor in history has recognised that mistakes of omission far outweigh mistakes of commission:
Charlie Munger, Buffett’s partner for over 60 years, put it bluntly:
“The big money is not in the buying or selling, but in the waiting. The huge returns come from holding great businesses through thick and thin.”
Philip Fisher, the father of growth investing whose book “Common Stocks and Uncommon Profits” influenced Buffett profoundly, wrote:
“If the job has been correctly done when a common stock is purchased, the time to sell it is — almost never.”
Fisher also observed that in his 70+ years of investing, the biggest mistakes he saw investors make were not buying bad stocks — it was selling outstanding companies too early because of minor concerns about valuation or short-term headwinds.
Thomas Rowe Price Jr., the founder of T. Rowe Price and a pioneer of growth investing, stated:
“The growth stock investor’s greatest enemy is not the bear market but the impulse to sell a winning investment too early.”
Rakesh Jhunjhunwala, India’s own legendary investor, was known for buying stocks he had previously sold — sometimes at much higher prices — when he became convinced the growth runway was longer than he initially estimated. His conviction in Titan Company (the watch and jewellery maker) deepened over time, and he repeatedly increased his position even as the stock climbed higher and higher.
Howard Marks, the legendary distressed debt investor and author of “The Most Important Thing,” summarised this brilliantly:
“There are two kinds of risks in investing — the risk of losing money and the risk of missing opportunity. You can eliminate one, but in doing so, you amplify the other.”
Buying back a stock you previously sold is not about blindly chasing prices. It requires a disciplined framework. Here are the conditions that justify buying back at a higher price:
1. The fundamental story has become STRONGER, not weaker. Revenue growth has accelerated. Margins have expanded. Return on equity has improved. The competitive moat has widened. If the business is objectively better today than when you sold it, the higher price may actually represent a BETTER deal in terms of future earnings power.
2. The upward trend is confirmed. The stock is making higher highs and higher lows. Institutional investors are increasing their positions. The quarterly results are consistently beating expectations. You are not catching a falling knife — you are joining a confirmed re-rating driven by genuine business improvement.
3. The management continues to execute. The same capable management team (or an even better one) is in place. Capital allocation remains disciplined. The company is investing in the right areas. There are no governance red flags.
4. The addressable market is larger than you initially estimated. Often, the reason a quality stock runs far beyond your selling price is that the growth opportunity turned out to be much bigger than the market (and you) originally thought. When you recognise this, adjusting your position upward is rational, not emotional.
5. The valuation, while higher in absolute price, is still reasonable relative to growth. A stock trading at ₹400 with ₹40 EPS (P/E of 10x) can be cheaper than the same stock at ₹200 with ₹10 EPS (P/E of 20x). Always think in terms of valuation multiples relative to growth, not absolute price.
Here is a mathematical truth that most investors do not internalise: if a company grows its earnings at 20% per year, its stock price will roughly double every 3.5 years (assuming constant valuation multiples). Over 10 years, that is approximately 6x. Over 15 years, approximately 15x. Over 20 years, approximately 38x.
When you sell a stock after a 100-200% gain, you have captured perhaps 3-5 years of a 20+ year compounding journey. You have picked up pennies and left gold bars on the ground. As Buffett’s right-hand man Charlie Munger observed, the first rule of compounding is to never interrupt it unnecessarily.
Consider this with Indian market data — with the SENSEX at approximately 73,583 (down 1,690 points as of March 27, 2026) and market volatility elevated due to geopolitical tensions and Goldman Sachs downgrading India to “market weight” — this is precisely the environment where quality stocks get mispriced. Quality businesses like those we study — including Titan Biotech Ltd (BSE: 524717), currently trading near ₹458, which has delivered over 417% returns in one year with a 52-week range of ₹74.73 to ₹458 — demonstrate exactly this compounding power when fundamentals consistently improve.
SEBI’s data confirms that over 90% of retail traders in F&O lose money chasing quick gains. Meanwhile, patient investors who hold (and re-buy) quality compounders build generational wealth. The contrast could not be starker.
Most investors obsess over the money they have lost on bad investments. Very few calculate the money they have failed to make by not owning quality businesses. Buffett calls these “the invisible losses” — and they are almost always far larger than the visible ones.
Think about it this way: if you had invested ₹1 lakh in HDFC Bank in 2001 and simply held, you would have approximately ₹35+ lakh today. If you sold after doubling your money (₹2 lakh) and parked the proceeds in a fixed deposit earning 7% annually, you would have approximately ₹7.6 lakh over the same period. The difference — nearly ₹27 lakh on a ₹1 lakh investment — is the cost of your mistake of omission.
Now multiply this across every quality stock you have sold too early in your investing career. The cumulative cost of omission is staggering for most investors.
Step 1: Make a list of every quality stock you sold in the last 5-10 years. Check their current price and fundamentals.
Step 2: For each stock, ask: “Are the fundamentals stronger today than when I sold?” If yes, it deserves serious consideration for re-purchase regardless of the current price being higher than your old selling price.
Step 3: Evaluate the current valuation relative to future growth. Use PEG ratio, DCF estimates, or simply compare current P/E to historical P/E and earnings growth rate.
Step 4: If the upward trend is confirmed and fundamentals keep improving, start building your position again. You do not need to buy your full position at once — accumulate gradually on dips.
Step 5: This time, commit to holding as long as the business keeps compounding. Do not repeat the same mistake. As Philip Fisher said, the time to sell a quality stock is almost never.
The refusal to buy back a quality stock at a higher price is ultimately an ego problem, not an investing problem. Your brain wants to be “right” — it wants to validate the decision to sell. Admitting that you sold too early feels like admitting a mistake. But the real mistake is not the early sale — it is the refusal to correct course when the evidence clearly tells you that you should.
Warren Buffett himself has bought back stocks at higher prices multiple times in his career. He has openly admitted that his biggest errors were not the bad investments he made but the great investments he failed to make — or failed to hold.
“The biggest mistakes are the mistakes of omission. We have missed profits of maybe $10 billion in things that I knew enough to do and I didn’t do.” — Warren Buffett
Do not let the next HDFC Bank, the next Infosys, or the next Asian Paints slip through your fingers for a mere 100-200% gain. The truly great compounders deliver 5,000%, 10,000%, even 50,000% returns over decades. Your job as a value investor is to identify them, hold them, and if you make the mistake of selling too early — have the courage and wisdom to buy them back, even at a higher price.
The upward trend, the improving fundamentals, and the growing competitive moat are all that matter. Not your ego. Not your old selling price. Not the fear of buying “expensive.” Quality always looks expensive in hindsight — until you realise it was actually cheap all along.
Disclaimer: This article is for educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Investing in stocks involves risk, including the risk of loss of principal. Past performance is not indicative of future results. Please consult a SEBI-registered investment advisor before making investment decisions. Titan Biotech is used as an educational example only.
Continue your value investing education: Watch our complete course playlist at YouTube Value Investing Course
📢 Join Our Telegram Channel
Get daily value investing lessons, stock analysis & Titan Biotech updates — delivered straight to your phone!
✈️ Join @longtermequityy on Telegram
🔔 Free • No spam • Value investing insights daily
Chat with us on WhatsApp